Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
McKesson
Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Mapatumumab

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Mapatumumab?

Mapatumumab is an investigational drug.

There have been 5 clinical trials for Mapatumumab. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2007.

The most common disease conditions in clinical trials are Carcinoma, Hepatocellular, Carcinoma, and Neoplasms, Plasma Cell. The leading clinical trial sponsors are Human Genome Sciences Inc., Human Genome Sciences Inc., a GSK Company, and GlaxoSmithKline.

Recent Clinical Trials for Mapatumumab
TitleSponsorPhase
Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular CarcinomaGlaxoSmithKlinePhase 2
Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular CarcinomaHuman Genome Sciences Inc., a GSK CompanyPhase 2
Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical CancerHuman Genome Sciences Inc.Phase 1/Phase 2

See all Mapatumumab clinical trials

Clinical Trial Summary for Mapatumumab

Top disease conditions for Mapatumumab
Top clinical trial sponsors for Mapatumumab

See all Mapatumumab clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Merck
Medtronic
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.